Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Luhui Pharmaceutical is a China-based pharmaceutical company and a key subsidiary of the Kelun Group. The company specializes in the research, development, and manufacturing of chemical drugs, with a core competency in advanced oral solid dosage forms, including sustained-release and controlled-release technologies. Its product portfolio is primarily focused on chronic disease management, covering therapeutic areas such as endocrinology, cardiovascular health, and gastroenterology. Sichuan Luhui operates large-scale, GMP-certified production facilities in Chengdu and serves as a strategic manufacturing hub for the broader Kelun Group. The company is recognized for its high-quality generic medications and its commitment to improving drug delivery efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Luhui Pharmaceutical.